James Chou

1.3k total citations
29 papers, 1.0k citations indexed

About

James Chou is a scholar working on Molecular Biology, Spectroscopy and Oncology. According to data from OpenAlex, James Chou has authored 29 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Spectroscopy and 6 papers in Oncology. Recurrent topics in James Chou's work include Spectroscopy and Laser Applications (6 papers), Laser Design and Applications (4 papers) and Connective Tissue Growth Factor Research (4 papers). James Chou is often cited by papers focused on Spectroscopy and Laser Applications (6 papers), Laser Design and Applications (4 papers) and Connective Tissue Growth Factor Research (4 papers). James Chou collaborates with scholars based in United States, Germany and Australia. James Chou's co-authors include Harold C. Neu, George W. Flynn, Roland E. Schmieder, P. Scigalla, Kai‐Uwe Eckardt, Wanja M. Bernhardt, Michael S. Wiesener, Volkmar Günzler, Mary Jeanne Kreek and Amy S. Mullin and has published in prestigious journals such as The Journal of Chemical Physics, Journal of Clinical Oncology and The Journal of Physical Chemistry.

In The Last Decade

James Chou

29 papers receiving 963 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James Chou United States 17 319 200 181 165 132 29 1.0k
Victoria J. Hammond United Kingdom 16 295 0.9× 43 0.2× 45 0.2× 84 0.5× 63 0.5× 27 910
Jane D. Roberts United States 16 201 0.6× 40 0.2× 38 0.2× 318 1.9× 80 0.6× 23 745
Duane R. Smith United States 19 320 1.0× 30 0.1× 40 0.2× 146 0.9× 59 0.4× 30 1.5k
Lijuan Zheng China 17 1.1k 3.4× 31 0.2× 177 1.0× 58 0.4× 45 0.3× 70 1.6k
Fariba Tayyari United States 18 615 1.9× 61 0.3× 187 1.0× 205 1.2× 54 0.4× 27 975
Ronald D. Brown United States 25 1.2k 3.8× 35 0.2× 205 1.1× 89 0.5× 69 0.5× 60 2.6k
Lennart C. Eriksson Sweden 26 897 2.8× 55 0.3× 273 1.5× 66 0.4× 41 0.3× 81 1.9k
Aberra Fura United States 20 423 1.3× 25 0.1× 22 0.1× 240 1.5× 63 0.5× 30 1.2k
Gregory J. Wells United States 22 697 2.2× 21 0.1× 48 0.3× 120 0.7× 21 0.2× 54 1.9k
Alan C. Rigby United States 25 1.6k 5.1× 184 0.9× 143 0.8× 97 0.6× 22 0.2× 58 2.7k

Countries citing papers authored by James Chou

Since Specialization
Citations

This map shows the geographic impact of James Chou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Chou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Chou more than expected).

Fields of papers citing papers by James Chou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Chou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Chou. The network helps show where James Chou may publish in the future.

Co-authorship network of co-authors of James Chou

This figure shows the co-authorship network connecting the top 25 collaborators of James Chou. A scholar is included among the top collaborators of James Chou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Chou. James Chou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rekić, Dinko, Mats Någård, James Chou, et al.. (2021). Pharmacokinetics of Roxadustat: A Population Analysis of 2855 Dialysis- and Non-Dialysis-Dependent Patients with Chronic Kidney Disease. Clinical Pharmacokinetics. 60(6). 759–773. 12 indexed citations
2.
Eichner, Daniel, Ryan M. Van Wagoner, James Chou, et al.. (2017). lmplementation of the prolyl hydroxylase inhibitor Roxadustat (FG‐4592) and its main metabolites into routine doping controls. Drug Testing and Analysis. 9(11-12). 1768–1778. 27 indexed citations
3.
Picozzi, Vincent J., J. Marc Pipas, Albert C. Koong, et al.. (2016). FG-3019, A Human Monoclonal Antibody to Connective Tissue Growth Factor, Combined with Chemotherapy in Patients with Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma. 2(1). 1–8. 8 indexed citations
4.
Brenner, Mitchell C., Wojciech Krzyżański, James Chou, et al.. (2016). FG-3019, a Human Monoclonal Antibody Recognizing Connective Tissue Growth Factor, is Subject to Target-Mediated Drug Disposition. Pharmaceutical Research. 33(8). 1833–1849. 26 indexed citations
6.
Picozzi, Vincent J., J. Marc Pipas, Albert C. Koong, et al.. (2013). FG-3019, a human monoclonal antibody to CTGF, with gemcitabine/erlotinib in patients with locally advanced or metastatic pancreatic ductal adenocarcinoma.. Journal of Clinical Oncology. 31(4_suppl). 213–213. 6 indexed citations
7.
Provenzano, Robert, James A. Tumlin, Raja I. Zabaneh, et al.. (2011). 254 Pharmacokinetics of Oral FG-4592 to Treat Anemia in Hemodialysis (HD) Patients (PTS). American Journal of Kidney Diseases. 57(4). B80–B80. 2 indexed citations
8.
Bernhardt, Wanja M., Michael S. Wiesener, P. Scigalla, et al.. (2010). Inhibition of Prolyl Hydroxylases Increases Erythropoietin Production in ESRD. Journal of the American Society of Nephrology. 21(12). 2151–2156. 254 indexed citations
9.
Leone‐Bay, Andrea, Masahiko Sato, Duncan R. Paton, et al.. (2001). Oral Delivery of Biologically Active Parathyroid Hormone. Pharmaceutical Research. 18(7). 964–970. 71 indexed citations
11.
Chou, James, et al.. (1997). A Radioimmunoassay for LY315902 an analog of Glucagon-like Insulinotropic Peptide, and Its Application in the Study of Canine Pharmacokinetics. Journal of Pharmaceutical Sciences. 86(7). 768–773. 17 indexed citations
12.
Chou, James, Brian T. Chait, Rong Wang, & Mary Jeanne Kreek. (1996). Differential biotransformation of dynorphin A(1–17) and dynorphin A(1–13) peptides in human blood, ex vivo. Peptides. 17(6). 983–990. 34 indexed citations
13.
Chou, James, et al.. (1996). Simplified quantitation of urinary benzoylecgonine in cocaine addiction research and for related pharmacotherapeutic trials. Addiction. 91(11). 1687–1697. 5 indexed citations
14.
Chou, James, et al.. (1996). Simplified quantitation of urinary benzoylecgonine in cocaine addiction research and for related pharmacotherapeutic trials. Addiction. 91(11). 1687–1697. 9 indexed citations
15.
Chauvet, Jacqueline, et al.. (1995). A new neurohypophysial peptide, seritocin ([Ser5,Ile8]‐oxytocin), identified in a dryness‐resistant African toad, Bufo regularis. International journal of peptide & protein research. 45(5). 482–487. 8 indexed citations
16.
Chou, James, Henrik Albeck, & M J Kreek. (1993). Determination of nalmefene in plasma by high-performance liquid chromatography with electrochemical detection and its application in pharmacokinetic studies. Journal of Chromatography B Biomedical Sciences and Applications. 613(2). 359–364. 10 indexed citations
18.
Chou, James, Scott A. Hewitt, John F. Hershberger, & George W. Flynn. (1990). Diode laser probing of the low frequency vibrational modes of baths of CO2 and N2O excited by relaxation of highly excited NO2. The Journal of Chemical Physics. 93(12). 8474–8481. 20 indexed citations
20.
Neu, Harold C. & James Chou. (1967). Release of Surface Enzymes in Enterobacteriaceae by Osmotic Shock. Journal of Bacteriology. 94(6). 1934–1945. 102 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026